Home > Publications database > Caracterización transcriptómica de bacterias relacionadas con eubiosis y disbiosis en pacientes con y sin carcinoma escamocelular oral > print |
001 | 275592 | ||
005 | 20240411140924.0 | ||
024 | 7 | _ | |2 doi |a 10.22354/24223794.1092 |
024 | 7 | _ | |2 ISSN |a 0123-9392 |
024 | 7 | _ | |2 ISSN |a 2422-3794 |
037 | _ | _ | |a DKFZ-2023-00803 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Erira, Alveiro |b 0 |
245 | _ | _ | |a Caracterización transcriptómica de bacterias relacionadas con eubiosis y disbiosis en pacientes con y sin carcinoma escamocelular oral |
260 | _ | _ | |a Medellín, Colombia |b ACIN |c 2022 |
336 | 7 | _ | |2 DRIVER |a article |
336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1682323615_14650 |
336 | 7 | _ | |2 BibTeX |a ARTICLE |
336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
536 | _ | _ | |0 G:(DE-HGF)POF4-314 |a 314 - Immunologie und Krebs (POF4-314) |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Gamboa, Fredy |b 1 |
700 | 1 | _ | |0 P:(DE-He78)a30064f6b2d9ab959d35315d7668c091 |a Cid-Arregui, Ángel |b 2 |u dkfz |
700 | 1 | _ | |a Tobar-Tosse, Fabian |b 3 |
700 | 1 | _ | |a García, Dabeiba A. |b 4 |
773 | _ | _ | |0 PERI:(DE-600)2090560-9 |a 10.22354/24223794.1092 |n 4 |p 425 - 434 |t Infectio |v 26 |x 0123-9392 |y 2022 |
909 | C | O | |o oai:inrepo02.dkfz.de:275592 |p VDB |
910 | 1 | _ | |0 I:(DE-588b)2036810-0 |6 P:(DE-He78)a30064f6b2d9ab959d35315d7668c091 |a Deutsches Krebsforschungszentrum |b 2 |k DKFZ |
913 | 1 | _ | |0 G:(DE-HGF)POF4-314 |1 G:(DE-HGF)POF4-310 |2 G:(DE-HGF)POF4-300 |3 G:(DE-HGF)POF4 |4 G:(DE-HGF)POF |a DE-HGF |b Gesundheit |l Krebsforschung |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2020-09-03 |
915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2020-09-03 |
915 | _ | _ | |0 StatID:(DE-HGF)0501 |2 StatID |a DBCoverage |b DOAJ Seal |d 2020-09-03 |
915 | _ | _ | |0 StatID:(DE-HGF)0500 |2 StatID |a DBCoverage |b DOAJ |d 2020-09-03 |
915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b DOAJ : Double blind peer review |d 2020-09-03 |
915 | _ | _ | |0 LIC:(DE-HGF)CCBYNCNDNV |2 V:(DE-HGF) |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version) |b DOAJ |d 2020-09-03 |
915 | _ | _ | |0 StatID:(DE-HGF)0561 |2 StatID |a Article Processing Charges |d 2020-09-03 |
915 | _ | _ | |0 StatID:(DE-HGF)0700 |2 StatID |a Fees |d 2020-09-03 |
920 | 1 | _ | |0 I:(DE-He78)D122-20160331 |k D122 |l D122 AG Gezielte Tumorvakzine |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D122-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|